These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6356125)

  • 1. [Synthesis of leukocyte migration inhibition factor in pulmonary tuberculosis patients with concomitant drug intolerance].
    Alenova AKh; Autenshlius AI; Mardanov SK
    Probl Tuberk; 1983 Jul; (7):34-8. PubMed ID: 6356125
    [No Abstract]   [Full Text] [Related]  

  • 2. Spontaneous production of lymphocyte migration inhibitory factor (sLyMIF) by T and B lymphocytes from peripheral rabbit blood.
    Skopińska E; Lukasik R
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):43-8. PubMed ID: 7025792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leukocyte migration inhibition test for functional evaluation of the T-lymphocyte population].
    Bilynskaia KhZ; Loginskiĭ VE
    Lab Delo; 1980; (5):316-7. PubMed ID: 6156295
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness of immunodiagnosis of drug intolerance in adolescents having tuberculosis and concomitant diseases].
    Rusakova LI; Gergert VI; Abramova ZP; Ovsiankina ES
    Probl Tuberk; 1997; (5):39-40. PubMed ID: 9454252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinico-biochemical characteristics of adverse reactions to antibacterial drugs in patients with pulmonary tuberculosis].
    Kostina ZI; Shaposhnikov AM; Ivanovskiĭ VB
    Probl Tuberk; 1978 Aug; (8):38-41. PubMed ID: 704581
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relation between drug intolerance and immunologic disorders in patients with pulmonary tuberculosis].
    Lomako MN; Abramovskaia AK; Batian AN; Batian ON
    Probl Tuberk; 1991; (5):51-4. PubMed ID: 1924244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte regulation of lymphokine production in cancer patients.
    Kowalczyk D; Ruggiero I; Zembala M
    J Clin Lab Immunol; 1986 Jan; 19(1):37-41. PubMed ID: 3517344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of hyposensitization in drug intolerance in patients with pulmonary tuberculosis].
    Spesivtsev OG; Prosvetov IuV; Gal'chanskaia LD
    Probl Tuberk; 1987; (12):30-3. PubMed ID: 3444822
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adverse reactions to antibacterial preparations during the treatment of tuberculosis among adolescents and their diagnosis].
    Firsova VA; Orlova LS; Ul'ianova VM; Timasheva ED
    Probl Tuberk; 1984 Nov; (11):33-6. PubMed ID: 6084248
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Agglomeration test in complications of chemotherapy of tuberculosis].
    Tuganova VE; Mats AN; Iusinova IP
    Klin Med (Mosk); 1975 Apr; 53(4):111-4. PubMed ID: 1152357
    [No Abstract]   [Full Text] [Related]  

  • 12. Migration inhibitory factor associated with delayed-type hypersensitivity.
    Bloom BR; Bennett B
    Fed Proc; 1968; 27(1):13-5. PubMed ID: 4952930
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinico-biomedical characteristics in manifestations of drug intolerance in patients with pulmonary tuberculosis].
    Sergeev IS; Ignatova AV
    Sov Med; 1973 Jul; 36(7):35-9. PubMed ID: 4776705
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of the cryopreservation on the production of leukocyte migration inhibition factor (LIF) by lymphocytes from normal volunteers and patients with laryngeal carcinomas.
    Cavallo GP; Beatrice F; Poggio E; Bussi M; Di Fortunato V; Rendine S; Sartoris A; Cortesina G
    Boll Ist Sieroter Milan; 1980 May; 59(2):147-54. PubMed ID: 7006629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Shelley's test in selection of drug therapy in tuberculous patients during preoperative period].
    Ogaĭ IV; Koviazina AI; Akmatov TA
    Probl Tuberk; 1974; (8):84-6. PubMed ID: 4410862
    [No Abstract]   [Full Text] [Related]  

  • 16. Requirement for B-lymphocyte alloantigen in the production of neutrophil migration inhibition factor from T lymphocytes (NIF-T).
    Weisbart RH; Billing R
    Immunology; 1980 Apr; 39(4):577-82. PubMed ID: 6991400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intolerance of medicinal preparations at different stages of the treatment of tuberculosis].
    Rudoĭ NM; Simonian LK; Repina LO
    Klin Med (Mosk); 1973 Mar; 51(3):80-3. PubMed ID: 4755486
    [No Abstract]   [Full Text] [Related]  

  • 18. Inflammatory, non-antibody lymphocytic mediators (lymphokines).
    Bendtzen K; Bendixen G
    Allerg Immunol (Leipz); 1980; 26(4):293-309. PubMed ID: 6163346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Side reactions, drug intolerance in antibacterial therapy and the state of the enzyme system, vascular permeability in patients with pulmonary tuberculosis].
    Fuks PM; Kononova II
    Sov Zdravookhr Kirg; 1970; 3():18-21. PubMed ID: 5492364
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vitamin A and carotene in patients with pulmonary tuberculosis with side effects of antibacterial therapy].
    Ignatova AV; Prokop'ev DI
    Probl Tuberk; 1966; 44(9):36-41. PubMed ID: 5994511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.